CDNA — CAREDX INC

Ownership history in Freestone Grove Partners LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in CAREDX INC (CDNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 19,678 +5,058 +34.6% 0.00% $286K $14.54
2024 Q4 INITIATED 14,620 — — 0.00% $313K $21.41
% of Fund (quarterly)    CDNA price (monthly, adj. close)

Other funds also holding CDNA

As of 2025 Q4 — sorted by position size

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 3Y 7Y 14.6% GAGNON SECURITIES LLC 3Y 7Y 6.81% Gagnon Advisors, LLC 3Y 7Y 6.37% Blue Water Life Science Advisors, LP 3Y 6.03% Bullseye Asset Management LLC 3Y 2.39% Ophir Asset Management Pty Ltd 3Y 1.96% Palo Alto Investors LP 3Y 7Y 1.25% Prosight Management, LP 3Y 7Y 0.97% BRAIDWELL LP 3Y 0.96% Zweig-DiMenna Associates LLC 3Y 7Y 0.79%
← Back to Freestone Grove Partners LP Holdings